TY - JOUR
T1 - Safety and efficacy of autologous haematopoietic stem-cell
transplantation with low-dose cyclophosphamide
mobilisation and reduced intensity conditioning versus
standard of care in refractory Crohn鈥檚 disease (ASTIClite):
an open-label, multicentre, randomised controlled trial
JO - The Lancet Gastroenterology and Hepatology
UR - https://eprints.whiterose.ac.uk/id/eprint/209060
PY - 2024/02/07
AU - Lindsay JO
AU - Hind D
AU - Swaby E
AU - Berntsson H
AU - Bradburn M
AU - Bannur U
AU - Byrne J
AU - Clarke C
AU - Desoysa L
AU - Dickins B
AU - Din S et al
ED -
DO - DOI: 10.1016/S2468-1253(23)00460-0
PB - Elsevier
Y2 - 2025/07/20
ER -